Clinical trial
A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in…
NCT00455013 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00455013 |
|---|---|
| Title | A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation |
| Official title | A Randomized, Open-Label, Multicenter, Parallel-Group Study of Belatacept (BMS-224818)-Based Corticosteroid-Free Regimens in Renal Transplant |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Disorder Related to Renal Transplantation |
| Intervention type | Drug |
| Interventions | Thymoglobulin, Belatacept, Sirolimus, Tacrolimus, Mycophenolate Mofetil (MMF) |
| Enrollment | 93 |
| Start date | Jul 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Aug 1, 2012 |
| First posted | Apr 2, 2007 |
| Last update posted | Jun 9, 2014 |
| Countries | Italy, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: